Please login to the form below

Not currently logged in


This page shows the latest GAD news and features for those working in and with pharma, biotech and healthcare.

Chasing the cure for Parkinson's disease

Chasing the cure for Parkinson's disease

NLX P101 uses adeno-associated virus-mediated transfer to introduce the gene for GAD into the brain. ... GAD converts glutamate (ie main excitatory neurotransmitter) into gamma-aminobutyric acid (GABA; main inhibitory neurotransmitter).

Latest news

  • Pfizer uses augmented reflection technology for mental health campaign Pfizer uses augmented reflection technology for mental health campaign

    Teams up with Anxiety UK to raise awareness of GAD.  . One of the striking images from Pfizer's video  . Pfizer UK has launched a new campaign that uses augmented reflection technology ... In Pfizer's case, as the new Let's Talk about GAD video shows,

  • Diabetes favoured

    GAD 65 antigen based. therapy for type 1 diabetes. Ongoing phase III.

  • An unexpected turn

    Quetiapine was launched for the treatment of schizophrenia and bipolar disorders, and is currently in preregistration for the treatment of depression and generalised anxiety disorder (GAD) in the US, with supplemental ... In another trial, patients with

  • Beating the system

    NLX-P101 uses an adeno-associated virus to carry the glutamic acid decarboxylase (GAD) gene into the neurones of the subthalamic nucleus - the part of the brain that is over-stimulated

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...